3D Bioprinting Market Segmentation, Growth Rate, Industrial Overview and Forecast 2022-2027

September 22 15:20 2022
3D Bioprinting Market Segmentation, Growth Rate, Industrial Overview and Forecast 2022-2027
3D Bioprinting Market
IMARC Group expects the global 3D bioprinting market to reach US$ 2,260.1 Million by 2027, exhibiting a CAGR of 16.85% during 2022-2027.

According to IMARC Group latest report titled “3D Bioprinting Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, offers a comprehensive analysis of the industry, which comprises insights on 3D bioprinting market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The global 3D bioprinting market reached a value of US$ 721.9 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 2,260.1 Million by 2027, exhibiting at a CAGR of 16.85% during 2022-2027.

3D bioprinting represents an additive manufacturing technique that is used for developing precise anatomical tissues via the decomposition of cell-based bio-inks. It usually involves various processes, including microstamping, stereolithography, direct and laser writing, photolithography, electro-printing, inkjet deposition, etc. The printer deposits several layers of biomaterials to build complex bodily structures, such as vascular grafts, skin, tracheal splints, bones, cartilages, etc. 3D bioprinting binds and assembles these components with dissolvable gel or collagen scaffolds to support and mold the cells into the desired shape.

Request to Get the Free Sample Report: https://www.imarcgroup.com/3d-bioprinting-market/requestsample  

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Market Trends:

The increasing prevalence of cardiovascular as well as respiratory diseases that require organ transplants is primarily driving the 3D bioprinting market. Additionally, the growing need for cancer therapeutics, regenerative medicines, and stem cell solutions is further catalyzing the market growth. Besides this, the widespread adoption of 3D bioprinting for liver modeling and the development of numerous tissue, bone, and medical implants is acting as another significant growth-inducing factor. Moreover, extensive R&D activities in the field of biotechnology, the rising utilization of bio-printed hair follicles and skin grafts to clinically test the products on human-like tissues, and the inflating popularity of magnetic levitation technology for toxicity screening and vascular muscle printing are also positively influencing the global market. Apart from this, the introduction of organ-on-a-chip that enables a 3D in-vitro analysis of bodily functions and the fabrication of artificial organs is anticipated to fuel the 3D bioprinting market over the forecasted period.

View Full Report with TOC & List of Figure: https://www.imarcgroup.com/3d-bioprinting-market

Competitive Landscape with Key players:

The report has also analysed the competitive landscape of the market with some of the key players being.

  • 3D Systems Inc.
  • Aspect Biosystems Ltd.
  • Cellink, Cyfuse Biomedical K.K.
  • EnvisionTEC GmbH (Desktop Metal Inc.)
  • GeSiM – Gesellschaft für Silizium-Mikrosysteme mbH
  • Materialise
  • Organovo Holdings Inc.
  • Poietis, RegenHU
  • Stratasys Ltd

3D Bioprinting Market Segmentation:

Our report has categorized the market based on region, component, application and end use industry.

Breakup by Component:

  • 3D Bioprinters
    • Syringe/Extrusion Bioprinting
    • Inkjet Bioprinting
    • Magnetic Levitation Bioprinting
    • Laser-assisted Bioprinting
    • Others
  • Scaffolds
  • Biomaterials
    • Living Cells
    • Hydrogels
    • Extracellular Matrices
    • Others

Breakup by Application:

  • Research
  • Drug Research
  • Regenerative Medicine
  • 3D Cell Culture
  • Clinical
  • Skin
  • Bone and Cartilage
  • Blood Vessels
  • Others

 Breakup by End User:

  • Hospitals
  • Research Organization and Academic Institutes
  • Biopharmaceuticals Companies

Breakup by Region:

  • North America (United States, Canada)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key highlights of the report:

  • Market Performance (2016-2021)
  • Market Outlook (2022-2027)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

We are updating our reports, If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Competitive landscape, etc. Click request free sample report, the report will be delivered to you in PDF format via email within 24 to 48 hours after the payment confirmation.

Other Reports of IMARC Group:

Glamping Market: https://www.imarcgroup.com/glamping-market

Medical Cyclotron Market: https://www.imarcgroup.com/medical-cyclotron-market

Medical Nonwoven Disposables Market: https://www.imarcgroup.com/medical-nonwoven-disposables-market

AIOps Market: https://www.imarcgroup.com/aiops-market

Air Taxi Market: https://www.imarcgroup.com/air-taxi-market

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Media Contact
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: Send Email
Phone: +1-631-791-1145
Address:30 N Gould St Ste R
City: Sheridan
State: WY
Country: United States
Website: https://www.imarcgroup.com

  Categories: